← Feed
Deep Dive
Matrix
Subscribe
☀
HBM HOLDINGS-B (02142.HK) Rises Over 5% on US Patent Infringement Lawsuit - AASTOCKS.com
www.aastocks.com
2026-06-15
AASTOCKS.com
Entities
Companies:
HBM Holdings
Amgen
Teneobio
Harbour Antibodies
Technologies:
patent infringement
legal damages
Tags
HBM Holdings
Patent Infringement
US District Court
Amgen
Teneobio
Harbour Antibodies
Biotechnology
Legal Litigation
Intellectual Property
Stock Price Rise
Pharmaceutical Industry
Damages Award
News Summary
HBM Holdings (02142.HK) saw its stock price rise over 5% following a favorable ruling in a U.S. patent infringement lawsuit. The case, initiated in 2021 by Harbour Antibodies, a subsidiary of HBM Hold...
Read original →
Read Original Article →
𝕏 Share
Facebook
LinkedIn
Reddit
Related
HBM HOLDINGS-B (02142) has dropped 5.098%. The last price is HK$9.68AA Market Mo
HBM Holdings Says NMPA Accepts IND Application For HBM7004 For Advanced Solid Tu
Why is HBM Holdings stock climbing today? By Investing.com - Investing.com Canad
Why is HBM Holdings stock climbing today? - Investing.com
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.